Ventas, Inc. logo VTR - Ventas, Inc.

Price: -- -- | CONSENSUS: Buy DETAILS
STRONG
BUY
0
BUY 18
HOLD 12
SELL 2
STRONG
SELL
0
| PRICE TARGET: $99.14 DETAILS
HIGH: $110.00
LOW: $88.00
MEDIAN: $100.00
CONSENSUS: $99.14
UPSIDE: 15.47%
AlphaVal

AlphaVal

Deterministic, archetype-aware fair value

Real Estate Investment Trust 85% confidence

Primary model: P/FFO × Healthcare REIT Multiple

Valuation Signal Overvalued Strong
Trading 60.5% above fair value
Current Price $85.86
Bear Case $42.44 50.6% downside ($42.44 - $85.86) / $85.86 = -50.6% $3.18 FFO × 15x
Fair Value $53.49 37.7% downside ($53.49 - $85.86) / $85.86 = -37.7% $3.18 FFO × 19x
Bull Case $64.55 24.8% downside ($64.55 - $85.86) / $85.86 = -24.8% $3.18 FFO × 23x

Adjust Assumptions

18.9x
3.18$

Key Value Driver

FFO/share ($3.18) × healthcare P/FFO multiple

Implied Market Multiple 27.0x

Plain-Language Summary

At $3.18 FFO/share with a 19x healthcare REIT multiple, the base-case value is $53.49 per share. Dividend yield: 2.4%. DDM cross-check: $38.27.

Analyst Consensus (External Reference)

Never blended into the bear/base/bull estimates above -- shown only as an outside comparison.

Average Target (32 analysts) $99.14
Analyst Range $88.00 – $110.00
Divergence from AlphaVal 46%

Warnings

⚠ Standard profit figures are misleading for real estate companies — large non-cash accounting charges make profits look artificially low. Dividend yield and funds from operations are better measures.
ℹ Dividend-based valuation: $38.27 (28% below our primary estimate). Large gaps suggest the dividend may not fully reflect the company's value.
ℹ Wall Street's average price target is $99.14 (from 32 analysts). Our estimate is 46% below the consensus -- consider that gap carefully.

Key Risks

  • P/E and EV/EBITDA are structurally wrong for REITs — use P/FFO and NAV
  • Interest rate sensitivity: REIT multiples compress when rates rise
  • FFO approximation (NI + D&A) may include gains on property sales — verify